In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 30th, 2005 | 24 | Yes |
Popular Name: Quinine Quinine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 130-89-2 , 130-95-0 , 146-40-7 , 303137-00-0 , 60-93-5 , 6119-47-7 , 6119-70-6 , 6151-40-2 , 804-63-7 , [130-89-2] , [130-95-0] , [549-56-4] , [6119-70-6] , [804-63-7]
"Quinine hydrochloride dihydrate, 99%"
"Quinine sulfate dihydrate, 99%"
(-)-Quinine; 130-95-0; C06526; Quinine
(1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol
(3|A,8|A,9r)-6'-methoxycinchonan-9-ol
(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol; sulfuric acid
(8-alpha,9R)-6'-Methoxycinchonan-9-ol
(8.alpha.,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-6'-Methoxycinchonan-9-ol
(9R)-6'-methoxy-8alpha-cinchonan-9-ol
(R)-(-)-Quinine, 6-methoxycinchonidine
(R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(R)-(6-Methoxyquinolin-4-yl)((1S,2S,4S,5R)-5-vinylquinuclidin-2-yl)methanol hydrochloride
(R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,4S,5R)-1-Aza-5-vinylbicyclo[2.2.2]oct-2-yl](6-methoxyquinolin-4-yl)methanol
(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
.alpha.-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol
146-40-7; D05681; Quinine ascorbate (USAN)
2-Quinuclidinemethanol, .alpha.-(6-methoxy-4-quinolyl)-5-vinyl-
2-Quinuclidinemethanol, alpha-(6-methoxy-4-quinolyl)-5-vinyl-
60-93-5; D08461; Quinine (TN); Quinine dihydrochloride
Biquinate (*Bisulfate heptathydrate*)
CHEBI:15001; CHEBI:569215; CHEBI:602929; CHEBI:127176; CHEBI:355947; CHEBI:8723; CHEBI:26499
Cinchonan-9-ol, 6'-methoxy-, (8-alpha,9R)-
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate
Cinchonan-9-ol, 6'-methoxy-, (8alpha,9R)-
Cinchonan-9-ol, 6'-methoxy-, (9S)-
Dentojel (*Bisulfate heptathydrate*)
NF); Quinine Ascorbate (USAN); Quinine Phosphate (NF); Quinine Bisulfate (MI
NF); Quinine Dihydrochloride (MI
NF); Quinine Glycerophosphate (NF)
NF); Quinine Glycerophosphate (NF); Quinine Hydrobromide (MI
NF); Quinine Hydrochloride (JAN
NF); Quinine Phosphate (NF); Quinine Ascorbate (USAN); Quinine Dihydrochloride (MI
Quinamm (*2:1 Sulfate salt*), dihydrate
Quine (*2:1 Sulfate salt*, dihydrate)
quinidinehydrochloridemonohydrate
QUININE ANHYDROUS, FOR FLUORESCENCE
QUININE ANHYDROUS, FOR FLUORESCENCE, 98.0%+
Quinine bisulfate; Quinine hydrogen sulfate; Quinine sulfate (2:1); Quinine sulfate anhydrous
Quinine hemisulfate monohydrate
Quinine hemisulfate monohydrate, 99%
Quinine hydrochloride dihydrate
Quinine monohydrochloride dihydrate
Quinine monohydrochloride dihydrate, 99% (total base), may contain up to 10% Dihydroquinine
Quinine sulfate (2:1) (salt) dihydrate
Quinine sulfate dihydrate, specified according to the requirements of USP
Quinine sulfate salt monohydrate
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.06 | 7.18 | -40.05 | 2 | 4 | 1 | 47 | 325.432 | 4 | ↓ |
Lo Low (pH 4.5-6) | 3.06 | 7.62 | -89.58 | 3 | 4 | 2 | 48 | 326.44 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
Molecular_Solubility | 5.444 | Bitter DB |
Mp [°C] | 176 - 177 | Acros Organics |
MP | 177 | TCI |
Melting_Point | 217-218? dec. | Alfa-Aesar |
Melting_Point | 217-218° dec. | Alfa-Aesar |
ALOGPS_SOLUBILITY | 3.34e-01 g/l | DrugBank-approved |
Purity | 95% | Fluorochem |
Purity | 99% | APIChem |
Target | Beta-glucuronidase(P08236)&Pyruvate kinase isozymes R/L(P30613)&Glutathione S-transferase P(P09211)&Neutrophil cytosol factor 1(P14598)&Transcription factor p65(Q04206)&Golgi-associated plant pathogenesis-related protein 1(Q9H4G4)&Membrane primary amine o | Herbal Ingredients Targets |
UniProt Database Links | CP3A4_HUMAN; GNAT3_BOVIN; GNAT3_MOUSE; GNAT3_RAT; GR33A_DROME; NAOX_LACLM; NHX1_ARATH; S22A1_BOVIN; S22A1_HUMAN; S22A1_MOUSE; S22A1_PIG; S22A1_RABIT; S22A1_RAT; SL9A7_HUMAN; TPO4_YEAST | ChEBI |
PUBCHEM_PATENT_ID | EP0000009A1; EP0000291A1; EP0000302A1; EP0001108A1; EP0001796A1; EP0004904A1; EP0007116A1; EP0007996A1; EP0008833A1; EP0009560A1; EP0010316A1; EP0010409A1; EP0010410A2; EP0010739A1; EP0013560A1; EP0013561A1; EP0014929A1; EP0017080A2; EP0017705A1; EP001790 | IBM Patent Data |
PUBCHEM_PATENT_ID | EP0148811A1; EP0293347A1; EP0293347B1; EP0326278A1; EP0351897A2; EP0371493A1; EP0371493B1; US3965256; US4189426; US4235870; US4780318; US5001161; US5081154; US5174998; US6099864; WO1989012391A1; WO1999059554A1 | IBM Patent Data |
Patent Database Links | EP1489070; EP1533300; EP1602926; EP1700601; EP1743892; EP1746090; EP1780203; EP1808173; EP1815846; EP1829527; EP1829528; EP1878445; EP1891958; EP1923702; EP1990346; US2002107266; US2002147238; US2004019111; US2005038024; US2005065213; US2005075338; US2005 | ChEBI |
H phrase | H302: Harmful if swallowed; H312: Harmful in contact with skin; H332: Harmful if inhaled; H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation | Acros Organics |
H phrase | H315: Causes skin irritation | Acros Organics |
H phrase | H315: Causes skin irritation; H319: Causes serious eye irritation; H302: Harmful if swallowed; H335: May cause respiratory irritation; H317: May cause an allergic skin reaction; H334: May cause allergy or asthma symptoms or breathing difficulties if inhal | Acros Organics |
Target | Others | Selleck Chemicals |
P phrase | P261: Avoid breathing dust/fume/gas/mist/vapors/spray | Acros Organics |
P phrase | P261: Avoid breathing dust/fume/gas/mist/vapors/spray; P280: Wear eye protection/face protection | Acros Organics |
P phrase | P261: Avoid breathing dust/fume/gas/mist/vapors/spray; P301+ P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell; P302+ P352: IF ON SKIN: Wash with plenty of soap and water; P280: Wear protective gloves/protective clothing/eye | Acros Organics |
Target | Potassium Channel | Selleck Chemicals |
R phrase | R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin. | Acros Organics |
R phrase | R22: Harmful if swallowed. | Acros Organics |
R phrase | R22: Harmful if swallowed.; R36/37/38: Irritating to eyes, respiratory system and skin.; R42/43: May cause sensitisation by inhalation and skin contact. | Acros Organics |
Reactome Database Links | REACT_15538; REACT_163726; REACT_22221; REACT_22239; REACT_22289; REACT_22348 | ChEBI |
S phrase | S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. | Acros Organics |
PUBCHEM_PATENT_ID | US5968867 | IBM Patent Data |
Hazard | XN: Harmful | Acros Organics |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SCN1A-1-E | Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4400 | 0.31 | Binding ≤ 10μM |
SCN2A-2-E | Sodium Channel Protein Type II Alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 4400 | 0.31 | Binding ≤ 10μM |
SCN3A-1-E | Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4400 | 0.31 | Binding ≤ 10μM |
SCN8A-1-E | Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 4400 | 0.31 | Binding ≤ 10μM |
CP2D6-1-E | Cytochrome P450 2D6 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 610 | 0.36 | ADME/T ≤ 10μM |
CP2DI-1-E | Cytochrome P450 2D18 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.34 | ADME/T ≤ 10μM |
CP2DQ-1-E | Cytochrome P450 2D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 94 | 0.41 | ADME/T ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 652 | 0.36 | Functional ≤ 10μM |
Z50426-6-O | Plasmodium Falciparum (isolate K1 / Thailand) (cluster #6 Of 9), Other | Other | 81 | 0.41 | Functional ≤ 10μM |
Z50460-2-O | Leishmania Major (cluster #2 Of 4), Other | Other | 9530 | 0.29 | Functional ≤ 10μM |
Z81138-1-O | ScN2a (Scrapie-infected Neuroblastoma Cells) (cluster #1 Of 3), Other | Other | 10000 | 0.29 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 4400 | 0.31 | Binding ≤ 10μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 4400 | 0.31 | Binding ≤ 10μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 4400 | 0.31 | Binding ≤ 10μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 4400 | 0.31 | Binding ≤ 10μM |
Z50460 | Z50460 | Leishmania Major | 9410 | 0.29 | Functional ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 100 | 0.41 | Functional ≤ 10μM |
Z50426 | Z50426 | Plasmodium Falciparum (isolate K1 / Thailand) | 12 | 0.46 | Functional ≤ 10μM |
Z81138 | Z81138 | ScN2a (Scrapie-infected Neuroblastoma Cells) | 10000 | 0.29 | Functional ≤ 10μM |
CP2DI_RAT | Q64680 | Cytochrome P450 2D18, Rat | 1700 | 0.34 | ADME/T ≤ 10μM |
CP2DQ_RAT | P10634 | Cytochrome P450 2D2, Rat | 94 | 0.41 | ADME/T ≤ 10μM |
CP2D6_HUMAN | P10635 | Cytochrome P450 2D6, Human | 1800 | 0.34 | ADME/T ≤ 10μM |
Description | Species |
---|---|
Class C/3 (Metabotropic glutamate/pheromone receptors) | |
G alpha (i) signalling events | |
Organic cation transport |
Description | Species |
---|---|
CYP2E1 reactions | |
Fatty acids | |
Interaction between L1 and Ankyrins | |
Miscellaneous substrates | |
Xenobiotics |